Money.net
Pfizer (PFE) Buys Coley At Huge Premium
Pfizer Inc (NYSE: PFE) entered into an agreement to acquire Coley Pharmaceutical Group, Inc. (NASDAQ: COLY) for $8 per share, or $164 million, a significant premium to yesterday's close of $3 per share.

Coley specializing in vaccine adjuvant technology and a new class of immunomodulatory drug candidates designed to fight cancers, allergy and asthma disorders, and autoimmune diseases.

Other small biotechs may be higher today on the news. Idera Pharmaceuticals, Inc. (AMEX: IDP) could be one.
SEC Filings (more headlines)
Pfizer (PFE) Buys Coley At Huge Premium
Pfizer Inc (NYSE: PFE) entered into an agreement to acquire Coley Pharmaceutical Group, Inc. (NASDAQ: COLY) for $8 per share, or $164 million, a significant premium to yesterday's close of $3 per share.

Coley specializing in vaccine adjuvant technology and a new class of immunomodulatory drug candidates... (continued)
American Community Properties Trust (APO) CEO Considering Taking Company Private
In an amended 13D filing on American Community Properties Trust (AMEX: APO), Chairman/CEO and 29.8% holder James Michael Wilson said he is evaluating a possible purchase of the remaining outstanding Common Shares of the Company not owned by them in a "going private" transaction.

James Michael Wilson has an agreement in principle to engage Granite... (continued)
Market Rumors 07/16
Market Rumors:

Verizon Communications (NYSE: VZ): Vodafone (NYSE: VOD) said it has has no plans to... (continued)
Trading Radar: 06/13
Trading Radar:

Retail Sales and Retail Sales ex-Autos are expected at 8:30AM ET with economists looking for 0.6% and 0.7%, respectively.

Import Price Index is expected at... (continued)
Dow Jones (DJ) Controlling Bancroft Family Seen Voting Against the News Corp Deal - CNBC
According to reports from CNBC, Dow Jones (NYSE: DJ) controlling Bancroft family is seen as not supporting the deal with News Corp. If the vote was today, more... (continued)
» See more headlines from this section